Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Cash flows from financing activities
Net cash provided by (used in) financing activities	$ 10
Net increase in cash and cash equivalents	10
Cash and cash equivalents
End of period	10		$ 10
EBS Intermediate Parent LLC
Cash flows from operating activities
Net income	8,054,000	$ 2,919,000	24,702,000	$ 2,011,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			4,664,000	4,165,000
Unit-based compensation	86,000	81,000	258,000	244,000
Non-cash interest expense; amortization of debt costs	208,000	53,000	399,000	159,000
Loss on debt modification			682,000
Changes in assets and liabilities
Prepaid expense and other current assets			(604,000)	550,000
Other assets			(1,585,000)	(2,961,000)
Accounts payable			291,000	(1,080,000)
Deferred revenue and patient deposits			1,100,000	336,000
Accrued and other liabilities			2,432,000	3,333,000
Net cash provided by operating activities			32,339,000	6,757,000
Cash flows from investing activities
Purchases of property and equipment, net			(4,726,000)	(2,543,000)
Net cash used in investing activities			(4,726,000)	(2,543,000)
Cash flows from financing activities
Payment on term loan			(626,000)	(301,000)
Borrowings on term loan, net			49,994,000	2,500,000
Distribution to member	2,844,000	293,000	(66,622,000)	(4,627,000)
Net cash provided by (used in) financing activities			(17,254,000)	(2,428,000)
Net increase in cash and cash equivalents			10,359,000	1,786,000
Cash and cash equivalents
Beginning of period			10,379,000	5,128,000
End of period	$ 20,738,000	$ 6,914,000	20,738,000	6,914,000
Supplemental disclosure of cash flow information:
Cash paid for interest			$ 2,722,000	$ 1,712,000